Sab Biotherapeutics Share Price (NASDAQ: SABS)
$2.05
Live
Last updated on
Check the interactive Sab Biotherapeutics Stock chart to analyse performance
Sab Biotherapeutics stock performance
as on August 30, 2025 at 12:10 am IST
- Today's Low:$2.05Today's High:$2.09
0.0%
Downside
Day's Volatility :1.91%
Upside
1.91%
- 52 Weeks Low:$1.0052 Weeks High:$6.60
51.22%
Downside
52 Weeks Volatility :84.85%
Upside
68.94%
Sab Biotherapeutics Stock Returns
Sab Biotherapeutics Inc Key Stats
Check Sab Biotherapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Sab Biotherapeutics Stock including INR - Dollar returns
The Sab Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sab Biotherapeutics investment value today
Current value as on today
₹75,867
Returns
Returns from Sab Biotherapeutics Stock
Dollar Returns*
₹5,177 (+5.18%)
Indian investors sentiment towards Sab Biotherapeutics Stock
Global Institutional Holdings in Sab Biotherapeutics Inc
Name
Holdings %
Bvf Inc
9.88%
Sessa Capital IM LP
4.93%
Vanguard Group Inc
3.04%
Geode Capital Management, LLC
0.91%
Pathstone Holdings LLC
0.55%
BlackRock Inc
0.24%
Analyst Recommendation on Sab Biotherapeutics Stock
Buy
87%Buy
12%Hold
0%Sell
Based on 8 Wall street analysts offering stock ratings for Sab Biotherapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Sab Biotherapeutics Share Price Target
What analysts predicted
Upside of 348.78%
Target:
$9.20
Current:
$2.05
Sab Biotherapeutics share price target is $9.20, a slight Upside of 348.78% compared to current price of $2.05 as per analysts' prediction.
Sab Biotherapeutics Stock Insights
Price Movement
In the last 7 days, SABS stock has moved down by -4.3%Increasing Revenue
Revenue is up for the last 2 quarters, -410.0 → 114.69K (in $), with an average increase of 100.4% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, -5.19M → -10.11M (in $), with an average decrease of 94.6% per quarterSABS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.5% return, outperforming this stock by 85.1%SABS vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.3% return, outperforming this stock by 191.6%Price to Sales
ForSABS every $1 of sales, investors are willing to pay $175.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.8 for every $1 of sales.
Sab Biotherapeutics Technicals Summary
Sell
Neutral
Buy
Sab Biotherapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Sab Biotherapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -7.08% | 22.81% | -27.59% | -73.42% | -97.12% |
 | 3.77% | -17.64% | -51.18% | -2.19% | -7.17% |
 | -0.02% | 10.33% | 51.07% | 81.16% | 24.14% |
 | -16.39% | -18.24% | -20.49% | 39.42% | 40.54% |
 | 33.05% | 83.22% | 57.52% | 115.32% | 240.85% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -2.21 | -1.27 | -0.57 | NA | 1.29 |
| 14.79 | 14.79 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.69 | 27.69 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $23.1M | -97.12% | NA | 0.0% |
| Buy | $62.2B | -7.17% | 14.79 | 31.37% |
| NA | $36.8B | 24.14% | NA | -3.89% |
| Buy | $99.8B | 40.54% | 27.69 | 31.86% |
| Buy | $59.1B | 240.85% | NA | -12.96% |
About Sab Biotherapeutics Inc
Key Management of Sab Biotherapeutics Inc
Important FAQs about investing in SABS Stock from India :
What is Sab Biotherapeutics share price today?
Sab Biotherapeutics share price today is $2.05 as on . Sab Biotherapeutics share today touched a day high of $2.09 and a low of $2.05.
What is the 52 week high and 52 week low for Sab Biotherapeutics share?
Sab Biotherapeutics share touched a 52 week high of $6.60 and a 52 week low of $1.00. Sab Biotherapeutics stock price today i.e. is trending at $2.05, lower by 68.94% versus the 52 week high.
How to invest in Sab Biotherapeutics Stock (SABS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Sab Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sab Biotherapeutics Shares that will get you 0.7317 shares as per Sab Biotherapeutics share price of $2.05 per share as on August 30, 2025 at 12:10 am IST.
What is the minimum amount required to buy Sab Biotherapeutics Stock (SABS) from India?
Indian investors can start investing in Sab Biotherapeutics (SABS) shares with as little as ₹88.167 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.67 in Sab Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on August 29, 2025).
Based on Sab Biotherapeutics share’s latest price of $2.05 as on August 30, 2025 at 12:10 am IST, you will get 4.8780 shares of Sab Biotherapeutics. Learn more about
fractional shares .
What are the returns that Sab Biotherapeutics has given to Indian investors in the last 5 years?
Sab Biotherapeutics stock has given -97.12% share price returns and 20.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Proshares Ultrapro Dow30 Etf$101.99
-0.98%
- Heartflow, Inc.
$30.66
-4.6%
Franklin Wireless Corp$4.38
+0.92%
- Vanguard Govt Sec Active Etf
$76.02
-0.03%
Cadrenal Therapeutics Inc$12.92
-2.78%
- Sandisk Corp
$50.98
+0.22%
Alliancebernstein Global High Income Fund Inc$11.28
-0.09%
- Franklin International Aggre
$20.46
-0.24%
Spdr Dow Jones Global Real Estate Etf$45.63
+0.29%